FDA Hits Guardian Drug for Lack of Quality Controls, Secure Data Post author:Sam Post published:April 11, 2017 Post category:Drug Industry Daily The FDA cited Guardian Drug Company over quality and data storage issues. Source: Drug Industry Daily You Might Also Like FDA Issues First Required Inspections Report, Covering 2017 March 28, 2018 COVID-19’s Gift to Pfizer: Record-Breaking 2021 Sales, Stellar 2022 Predictions February 8, 2022 Catalyst, Jacobus Settle Patent Dispute Over LEMS Drug Ruzurgi July 12, 2022
